Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort studyHirokazu Kagawa, Takafumi Yanagisawa, Kojiro Tashiro et al.|International Journal of Clinical Oncology|2023Cited by 10
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective studyFumihiko Urabe, Naoki Uchida, Hirokazu Kagawa et al.|Japanese Journal of Clinical Oncology|2025Cited by 6
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective studyFumihiko Urabe, Takahiro Kimura, Hirokazu Kagawa et al.|Prostate International|2024Cited by 6
Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI scoreYuya Iwamoto, Takahiro Kimura, Halle Foss et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 5
Initial Experience of Robot‐Assisted Nephrectomy and Nephroureterectomy Using the Novel Saroa Surgical SystemKosuke Iwatani, Jun Miki, Fumihiko Urabe et al.|International Journal of Urology|2025Cited by 4